Pendulum Therapeutics

📍 San Francisco, United States🗓 Founded 2012👥 110 employees💰 Last funded Aug 2026
Biotechnology🌐 pendulum.co
Website LinkedIn
Pendulum Therapeutics is the leading innovator in microbiome science, delivering research based probiotic formulations to support metabolic health. The company leverages cutting-edge research and strong intellectual property to bring effective, science-backed solutions to consumers worldwide. Pendulum Akkermansia was the first novel species to be brought to the probiotics market in more than 50 years. The first and only probiotic in the world clinically proven to lower A1C and blood glucose in people with type 2 diabetes, Akkermansia stimulates natural GLP-1 production.
4
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
New Zealand
1
Investor activity2021–2026 · investors recorded per year
20211202312024120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Pendulum Therapeutics?
Pendulum Therapeutics has 4 investors on record on gritt.io and 1 late-stage investors.
When did Pendulum Therapeutics last raise funding?
The most recent investment in Pendulum Therapeutics recorded on gritt.io was in August 2026.
When was Pendulum Therapeutics founded?
Pendulum Therapeutics was founded in 2012.
What industry is Pendulum Therapeutics in?
Pendulum Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Pendulum Therapeutics based?
Pendulum Therapeutics is headquartered in San Francisco, United States.